SCHEMBL17066735

SCHEMBL17066735

Cc1ccc(-c2ccc(-c3cnc(C)[nH]3)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.55
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
SMPD3 Q9NY59 1/20 0.46
CDK5 Q00535 2/20 0.44
GSK3B P49841 2/20 0.44
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
GSK3A P49840 1/20 0.44
CDK5R1 Q15078 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
ABL1 P00519 1/20 0.42
RET P07949 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17066723 1.00 CYP2A6 (0.55) CYP2A6MAPTMEN1LMNACYP1A2
SCHEMBL15747113 0.98 CYP2A6 (0.56) CYP2A6MAPTMEN1LMNACYP1A2
SCHEMBL14985690 0.87 CYP2A6 (0.47) CYP2A6MAPTMEN1LMNACYP1A2
SCHEMBL7483325 0.82 CYP2A6 (0.53) CYP2A6MAPTCDK5GSK3BCCNB2
SCHEMBL17533003 0.82 CYP2A6 (0.53) CYP2A6MAPTMEN1LMNACYP1A2
SCHEMBL24427567 0.82 CYP2A6 (0.53) CYP2A6MAPTMEN1CYP3A4KMT2A
SCHEMBL9668668 0.82 CYP2A6 (0.53) CYP2A6MAPTMEN1KMT2ACDK5
SCHEMBL7904690 0.82 POLB (0.61) CYP2A6MAPTCCNB2CDK1CCNB1
SCHEMBL28559389 0.82 CYP2A6 (0.53) CYP2A6MEN1KMT2ASMPD3CDK5
SCHEMBL5292919 0.81 CYP2A6 (0.67) CYP2A6SMPD3CDK5CCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9125904-B1 Biphenyl imidazoles and related compounds useful for treating HCV infections ACHILLION PHARMACEUTICALS, INC. (US) 2015-09-08 US disclosed